Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elosulfase Alfa in MPS IVA (Morquio A Syndrome)
NCT01275066Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Feb 2011
- Primary completion
- Aug 2012
- Modality
- Replacement Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of elosulfase alfa in Mucopolysaccharidosis type IV A, sponsored by BioMarin Pharmaceutical. Started Feb 2011; status: completed.
02
Drugs
elosulfase alfa
03
Conditions
Mucopolysaccharidosis type IV A
Beyond the preview
Go deeper on NCT01275066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01275066.